Tianjin, China and TaicangMay 22, 2026 /PRNewswire/ — Recently, Novonesis, a global leader in biological solutions, held completion and inauguration ceremonies for key projects in the Tianjin Economic-Technological Development Area (TEDA) and Taicang, Jiangsu. The Danish Ambassador to China, the Danish Consul General in Shanghai, and local government representatives witnessed this landmark moment, underscoring the company’s steadfast commitment to deepening its presence in the Chinese market and driving green transformation and the bioeconomy.
On May 19, at the Tianjin event, a representative from the Tianjin Economic-Technological Development Area Management Committee and the Danish Ambassador to China attended the ceremony, joining Novonesis Chief Operating Officer Anders Lund and other senior executives to launch the new administrative office building project. This project represents a significant upgrade to the company’s operational system in China, enhancing internal collaboration efficiency, comprehensively refreshing the employee experience, and broadening the exchange platform with external partners, marking an important milestone in the company’s deepening development in China.
Novonesis Tianjin Economic-Technological Development Area Project Completion and Inauguration Event
During the event, company and government representatives engaged in in-depth discussions on the development of the biomanufacturing industry, green transformation, and innovation collaboration. Novonesis Chief Operating Officer Anders Lund stated that the completion of this project is not only a significant milestone for the Tianjin factory but also a new starting point for the company to deepen its layout in China and collaborate with all parties to promote the bioeconomy. As a key global multi-purpose enzyme production base, the Tianjin factory produces over 140 products covering a wide range of industries. The company will continue to invest, expand capacity, and advance intelligent and green upgrades, aiming to achieve approximately 20% capacity growth by 2027. Moving forward, Novonesis will leverage Tianjin as a crucial global production and innovation hub to fully harness the potential of biological solutions, providing Chinese customers and consumers with more efficient and sustainable products and services.
On May 21, at the factory project completion event in Taicang, Jiangsu, relevant leaders from the Taicang municipal government and the Danish Consul General in Shanghai attended as key guests to witness the launch of the new project. During the event, Novonesis signed a Memorandum of Understanding (MoU) with the local government to further deepen government-enterprise cooperation. The two sides will collaborate on industrial upgrading, green development, and accelerating the construction and development of the biomanufacturing industry.
Novonesis Jiangsu Taicang Factory Project Completion Event
The Taicang project, as a key strategic pillar of Novonesis’s layout in China, has continued to grow and develop since its initial investment in 1994. The official launch of the newly built office and quality control laboratory facilities marks a comprehensive upgrade in the base’s governance capabilities, quality standards, and innovation capacity. The company stated that it will continue to invest resources, planning to add several hundred million RMB in new investment in Taicang in 2026 to launch an expansion project, continuously injecting strong new momentum into its development in Taicang.
Novonesis Chief Operating Officer Anders Lund stated in his speech that the company has been officially present in the Chinese market for over 30 years, consistently adhering to a localization development and long-term investment strategy. The successive completion of the Tianjin and Taicang projects is a powerful testament to the company’s continued commitment to China and its pursuit of high-quality development. The company will continue to leverage core technologies such as microorganisms, enzymes, and functional proteins to drive innovative applications in areas such as food health, green manufacturing, and the circular economy.
Novonesis Chief Operating Officer Anders Lund
Novonesis, formed by the integration of Danish biotechnology companies Novozymes and Chr. Hansen, has over 10,000 employees worldwide. In China, it has operations in six cities, including Beijing, Tianjin, Suzhou Taicang, Shenyang, Shanghai, and Guangzhou, covering three business areas: Food & Beverages, Human Health, and Planetary Health.
Several attending government representatives stated that Novonesis’s long-term roots in China have not only provided strong support for local economic development but also played an active role in promoting green and low-carbon transformation and fostering international industrial cooperation. In the future, the government will continue to optimize the business environment, support the company in expanding investment and strengthening innovation, and jointly cultivate new momentum for the development of the bioeconomy.
Novonesis stated that China is one of the most important development markets globally. The company will continue to deepen cooperation with governments at all levels, research institutions, and industry partners, promote the large-scale application of biomanufacturing, contribute to achieving the “dual carbon” goals and industrial structure upgrading, and contribute to the high-quality development of China’s economy and global sustainable development.